Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin

Clinical trial NCT04204837 · RECRUITING

Trial details

NCT number: NCT04204837
Sponsor: Salzburger Landeskliniken
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Skin

Start date: 2017-03-06
Primary completion: 2026-12-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.